Iridex Corporation ... Transscleral Laser Therapy (TLT) in treating primary and secondary glaucoma over five years. Conducted by Dr. Ronald de Crom at the University Eye Clinic Maastricht, the ...

Iridex Corporation (Nasdaq: IRIX), a worldwide leader providing innovative and versatile laser-based medical systems and delivery devices for the treatment of glaucoma and retinal diseases ...

Iridex Corporation (Nasdaq: IRIX), a worldwide leader providing innovative and versatile laser-based medical systems and delivery devices for the treatment of glaucoma and retinal diseases ...

For the entire year, revenue is expected between $48.6 million and $48.7 million, a decline from 2023, alongside a drop in probe and laser system ... threatening eye conditions. Iridex’s current ...

and marketing innovative and versatile laser-based medical systems, delivery devices and consumable instrumentation for the ophthalmology market. The Company's proprietary MicroPulse® technology ...